GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Aprogen Medicines Inc (XKRX:007460) » Definitions » Research & Development

Aprogen Medicines (XKRX:007460) Research & Development : ₩42,817 Mil (TTM As of Dec. 2023)


View and export this data going back to 1995. Start your Free Trial

What is Aprogen Medicines Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Aprogen Medicines's Research & Development for the three months ended in Dec. 2023 was ₩10,319 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was ₩42,817 Mil.

Aprogen Medicines Research & Development Historical Data

The historical data trend for Aprogen Medicines's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aprogen Medicines Research & Development Chart

Aprogen Medicines Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,870.90 1,028.61 32,780.10 38,560.52 42,817.39

Aprogen Medicines Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,697.62 16,804.16 -1,781.78 17,475.84 10,319.17

Aprogen Medicines Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩42,817 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aprogen Medicines  (XKRX:007460) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Aprogen Medicines Research & Development Related Terms

Thank you for viewing the detailed overview of Aprogen Medicines's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Aprogen Medicines (XKRX:007460) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Aprogen Medicines Inc (XKRX:007460) » Definitions » Research & Development
Comparable Companies
XKRX:122640 XKRX:382840 XKRX:090360 XKRX:030530 XKRX:011810 XKRX:297090 XKRX:217820 XKRX:161580 XKRX:277880 XKRX:126720 GE XTER:SIE XPAR:SU ETN XKRX:373220 ITW OSTO:ATCO A EMR PH AME
Traded in Other Exchanges
N/A
Address
545, Dunchon-daero, B1 Floor, Jungwon-gu, Sangdaewon-dong, Hallasigma valley,, Gyeonggi-do, Seongnam-si, KOR
Website
https://www.aprogen.com
Aprogen Medicines Inc, formerly Aprogen KIC Inc manufactures and maintains plant equipment for the industrial furnace and oven sector. Its business divisions include plant, fired heater, hard facing, and thermal insulation works.

Aprogen Medicines (XKRX:007460) Headlines

No Headlines